DEF 14A

Company

GRI Bio, Inc.

Filed

January 2, 2024

Period of Report

January 2, 2024

Accession Number

0001824293-23-000187

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →